{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inflammatory+Bowel+Syndrome&page=3", "query": { "condition": "Inflammatory Bowel Syndrome", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 98, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inflammatory+Bowel+Syndrome&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inflammatory+Bowel+Syndrome&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-04T01:48:08.387Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03816345", "title": "Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Autoimmune Disease", "Crohn Disease", "Dermatomyositis", "Hematopoietic and Lymphoid Cell Neoplasm", "Inflammatory Bowel Disease", "Malignant Solid Neoplasm", "Multiple Sclerosis", "Psoriasis", "Psoriatic Arthritis", "Rheumatoid Arthritis", "Sjogren Syndrome", "Systemic Lupus Erythematosus", "Systemic Scleroderma", "Ulcerative Colitis" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Cabozantinib", "type": "DRUG" }, { "name": "Fluoropyrimidine", "type": "DRUG" }, { "name": "Ipilimumab", "type": "BIOLOGICAL" }, { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "Platinum Compound", "type": "DRUG" }, { "name": "Platinum Doublet", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2019-07-16", "completion_date": "2028-03-30", "has_results": false, "last_update_posted_date": "2026-09-23", "last_synced_at": "2026-10-04T01:48:08.387Z", "location_count": 51, "location_summary": "Birmingham, Alabama • Palo Alto, California • Sacramento, California + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03816345" }, { "nct_id": "NCT00254176", "title": "Cysteine Supplementation in Critically Ill Neonates", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Sepsis", "Bronchopulmonary Dysplasia", "Necrotizing Enterocolitis", "Retinopathy of Prematurity", "Systemic Inflammatory Response Syndrome" ], "interventions": [ { "name": "Parenteral cysteine-HCl supplementation", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo - added premasol", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "30 Days", "sex": "ALL", "summary": "Up to 30 Days" }, "enrollment_count": 108, "start_date": "2006-09", "completion_date": "2011-07", "has_results": false, "last_update_posted_date": "2010-02-26", "last_synced_at": "2026-10-04T01:48:08.387Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00254176" }, { "nct_id": "NCT07284641", "title": "Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Common Variable Immunodeficiency (CVID)", "Primary Immune Regulatory Disorder", "Immune Dysregulation", "DiGeorge Syndrome", "STAT 1 Gain of Function", "STAT 3 Gain of Function", "Hypomorphic RAG1 Deficiency", "CD40 Ligand Deficiency", "Mendelian Susceptibility to Mycobacterial Disease", "GATA2 Associated Immunodeficiency", "CD40 Deficiency", "Hypomorphic RAG2 Deficiency", "Immune Dysregulation Polyendocrinopathy Enteropathy X-Linked Syndrome", "Omenn Syndrome", "Chronic Granulomatous Disease" ], "interventions": [ { "name": "Hematopoietic stem cell transplant (HSCT)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Paul Szabolcs", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "5 Years to 40 Years" }, "enrollment_count": 25, "start_date": "2026-05-04", "completion_date": "2031-02-01", "has_results": false, "last_update_posted_date": "2026-05-15", "last_synced_at": "2026-10-04T01:48:08.387Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07284641" }, { "nct_id": "NCT03555617", "title": "Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Inflammatory Bowel Disease" ], "interventions": [ { "name": "TD-1473", "type": "DRUG" }, { "name": "Itraconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Theravance Biopharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "19 Years to 55 Years" }, "enrollment_count": 36, "start_date": "2018-06-13", "completion_date": "2018-07-15", "has_results": false, "last_update_posted_date": "2021-01-14", "last_synced_at": "2026-10-04T01:48:08.387Z", "location_count": 1, "location_summary": "Lincoln, Nebraska", "locations": [ { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT03555617" }, { "nct_id": "NCT01656746", "title": "Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Adenomatous Polyp", "Crohn Disease", "Familial Adenomatous Polyposis", "Hereditary Intestinal Polyposis Syndrome", "Recurrent Colon Cancer", "Stage I Colon Cancer", "Stage IIA Colon Cancer", "Stage IIB Colon Cancer", "Stage IIC Colon Cancer", "Stage IIIA Colon Cancer", "Stage IIIB Colon Cancer", "Stage IIIC Colon Cancer" ], "interventions": [ { "name": "therapeutic laparoscopic surgery", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Ohio State University Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 10, "start_date": "2010-05", "completion_date": "2013-10", "has_results": false, "last_update_posted_date": "2017-12-06", "last_synced_at": "2026-10-04T01:48:08.387Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01656746" }, { "nct_id": "NCT01962415", "title": "Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Primary Immunodeficiency (PID)", "Congenital Bone Marrow Failure Syndromes", "Inherited Metabolic Disorders (IMD)", "Hereditary Anemias", "Inflammatory Conditions", "Systemic Juvenile Idiopathic Arthritis (sJIA)", "Juvenile Rheumatoid Arthritis (JRA)" ], "interventions": [ { "name": "Hydroxyurea", "type": "DRUG" }, { "name": "Alemtuzumab", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "Thiotepa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Paul Szabolcs", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "55 Years", "sex": "ALL", "summary": "2 Months to 55 Years" }, "enrollment_count": 100, "start_date": "2014-02-04", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2025-12-15", "last_synced_at": "2026-10-04T01:48:08.387Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01962415" }, { "nct_id": "NCT00840983", "title": "Effects of Delayed Cord Clamping in Very Low Birth Weight Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Bronchopulmonary Dysplasia", "Necrotizing Enterocolitis", "Intraventricular Hemorrhage", "Late Onset Neonatal Sepsis", "Motor Skills Disorders" ], "interventions": [ { "name": "delayed cord clamping", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Rhode Island", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 72, "start_date": "2003-08", "completion_date": "2006-12", "has_results": false, "last_update_posted_date": "2015-11-30", "last_synced_at": "2026-10-04T01:48:08.387Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT00840983" }, { "nct_id": "NCT06810518", "title": "ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)", "Inflammatory Bowel Syndrome" ], "interventions": [ { "name": "ALPCO Calprotectin CLIA", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "American Laboratory Products Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 220, "start_date": "2025-03-25", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-04-28", "last_synced_at": "2026-10-04T01:48:08.387Z", "location_count": 3, "location_summary": "Miami, Florida • Salem, New Hampshire • Westlake, Ohio", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Salem", "state": "New Hampshire" }, { "city": "Westlake", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06810518" }, { "nct_id": "NCT01517516", "title": "Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest.", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Irritable Bowel Syndrome", "Cyclical Vomiting Syndrome", "Ulcerative Colitis", "Vulvodynia", "Crohn's Disease" ], "interventions": [], "intervention_types": [], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 165, "start_date": "2011-03", "completion_date": "2015-07", "has_results": false, "last_update_posted_date": "2016-01-14", "last_synced_at": "2026-10-04T01:48:08.387Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01517516" }, { "nct_id": "NCT05318183", "title": "Assessing Gut Microbiota Mediated Health Outcomes of Whole Wheat and Its Major Bioactive Components", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "PreDiabetes", "Dysbiosis", "Endotoxemia", "Inflammation" ], "interventions": [ { "name": "Whole Wheat Bread", "type": "OTHER" }, { "name": "White Bread (control)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 65, "start_date": "2022-01-27", "completion_date": "2026-05-30", "has_results": true, "last_update_posted_date": "2025-11-20", "last_synced_at": "2026-10-04T01:48:08.387Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05318183" } ] }